Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTFAST SWISS: Atorvastatin for LDL-C target
NCT00136942Phase 3Completed
- Sponsor
- Viatris
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of atorvastatin in hyperlipidemia (4 arms), sponsored by Viatris. Primary endpoint: Proportion of patients achieving LDL-C target as defined by Swiss cholesterol recommendations (AGLA-recommendations) at 6 weeks. Started Apr 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00136942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136942.